CDMOs are the talk of the town in India’s pharma landscape, with the market projected to grow at ~15% CAGR, reaching ~$45 billion by 2029.
Very well drafted with good insights
I read your analysis on Hikal but it's underperforming for years and their recent commentary is also muted and even people who were bullish on this are turning bearish now.
Very good insights….is it possible to do the same for lauras lab also?
Very helpful. Thank you
Great read, in-depth analysis on CDMO story, goodjob👍
Kudos on this very informative and insightul note on Hikal.
Very nicely done writeup Deepak. Kudos. Keep it up pls 👍
Gr88 insight will full details
Thank for update its very helpful.
Please keep it up.
Very well drafted with good insights
I read your analysis on Hikal but it's underperforming for years and their recent commentary is also muted and even people who were bullish on this are turning bearish now.
Very good insights….is it possible to do the same for lauras lab also?
Very helpful. Thank you
Great read, in-depth analysis on CDMO story, goodjob👍
Kudos on this very informative and insightul note on Hikal.
Very nicely done writeup Deepak. Kudos. Keep it up pls 👍
Gr88 insight will full details
Thank for update its very helpful.
Please keep it up.